NLRP3 and androgen insensitivity syndrome: AIS patients showed significantly elevated serum NLRP3 (56.59 pg/mL vs. 33.24 pg/mL) and occludin levels (97.42 ng/mL vs. 44.54 ng/mL) (both p <0.001).